VIREAD tenofovir disoproxil fumarate - PowerPoint PPT Presentation

1 / 6
About This Presentation
Title:

VIREAD tenofovir disoproxil fumarate

Description:

Presented at IAS USA/RWCA Clinical Conference, August 2004. ... Changing Treatment Guidelines: DHHS: Asymptomatic patients. offer, but controversy exists ... – PowerPoint PPT presentation

Number of Views:283
Avg rating:3.0/5.0
Slides: 7
Provided by: haw4
Category:

less

Transcript and Presenter's Notes

Title: VIREAD tenofovir disoproxil fumarate


1

Initiation of Antiretroviral Therapy Is Once
Enough?
Michael S. Saag, MD
MS Saag, MD.Presented at IASUSA/RWCA Clinical
Conference, August 2004.
The International AIDS SocietyUSA
2
When to Start Recommendations for Initiating
Therapy
Yeni et al, for IASUSA. JAMA, 2004.
3
Changing Treatment Guidelines DHHS Asymptomatic
patients
ltwww.aidsinfo.nih.govgt
4
AIDS free survival by log HIV-1 RNA at baseline

1.00
lt3
3-3.99
0.95
4-4.99
0.90

Probability of AIDS free survival

gt5
0.85
0.80
0.75
0
1
2
3
Years from starting HAART
5
Initial Regimens
  • Generally Recommended
  • NNRTI 2 NRTIs
  • Boosted PI 2 NRTIs
  • Generally NOT Recommended
  • 4-drug regimens
  • 3-NRTI regimens, except when NNRTI and PI use is
    precluded
  • 2-drug regimens or monotherapy (eg, 1 PI)

6
FTC-301 Efficacy Endpoints at Week 48
Saag et al, JAMA, 2004.
Write a Comment
User Comments (0)
About PowerShow.com